Navigation Links
Generex in Agreement to License RapidMist™ Technology for $10 Million to Amarantus BioSciences for Use With Its Proprietary MANF Proteins
Date:5/31/2011

WORCESTER, Mass. and TORONTO, May 31, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT) (www.generex.com) today announced that it has entered into a binding letter agreement to license its RapidMist™ buccal drug delivery technologies to Amarantus BioSciences, Inc. (www.amarantus.com), a California-based biotechnology company, for use with its proprietary MANF proteins in exchange for a non-refundable license fee of $10 million.  In addition, the companies will jointly pursue the use of technologies developed by Amarantus for the treatment of diabetes mellitus.  

(Logo: http://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b)

MANF is a newly discovered protein by the scientific team at Amarantus that mediates the biological process known as apoptosis (programmed cell death) throughout the body.  This special property has been scientifically demonstrated in various pre-clinical models of human disease, indicating that MANF-based products could have a significant impact on the treatment of a myriad of human diseases as first-in-class treatments. Amarantus' most advanced product development program for MANF centers on the development of a disease-modifying therapy for Parkinson's disease currently funded by the Michael J. Fox Foundation for Parkinson's Research.

Under the terms of the agreement, Generex will grant to Amarantus an exclusive worldwide license for the clinical & regulatory development and commercialization of Generex's proprietary RapidMist™ technologies in connection with any and all therapeutic applications of MANF technologies developed by Amarantus in all fields except the treatment of diabetes.  Amarantus will pay a license fee of $10 Million to Generex, which fee will be paid in Amarantus common stock valued at not less than $5 Million and a three-year promissory note.  In addition, Generex
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Generex Biotechnology Corporation CEO Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
2. Generex Biotechnology Corporation CEO to Present Live, Online at RetailInvestorConferences.com on May 5th
3. Generex Launches New Corporate Website
4. Generex Unveils Strategic Development Plan
5. Generex Plans Rights Offering Upon Approval of Reverse Stock Split and Listing on a National Stock Exchange
6. Generex Provides Further Information for March 30 Press Conference & Investor Call to Discuss Managements Strategic Development Plan for Future Growth
7. Generex Schedules Press Conference & Investor Call for March 30th to Discuss Managements Strategic Development Plan for Future Growth
8. Generex Announces New Treatment IND Site for the USFDA Expanded Access Treatment IND Program for Generex Oral-lyn™ in the United States
9. Generex Oncology Receives New Patent for AE37 Immunotherapeutic Cancer Vaccine
10. Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study
11. Generex and RXi Pharmaceuticals Announce Positive Research Data Using RNAi Technology in the Development of Therapeutic Vaccines for Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 This report analyzes the worldwide markets ... the following Segments: Standard Intraocular Lenses, and Premium Intraocular Lenses. ... Canada , Japan , ... Latin America , and Rest of World. Annual ... 2020. Also, a seven-year historic analysis is provided for these ...
(Date:5/28/2015)... Research and Markets ( ... the  "North America Ultrasound Devices Market - ...  report to their offering.       ... type of imaging. It uses high-frequency sound ... structures inside the body. Health care experts ...
(Date:5/28/2015)... , May 28, 2015 KaloBios Pharmaceuticals, Inc. ... Ronald A. Martell , to the position of ... of the KaloBios Board of Directors. In this new ... management team to refine and execute on the strategic ... company developing therapeutics for orphan oncology indications with high ...
Breaking Medicine Technology:World Intraocular Lenses Industry 2World Intraocular Lenses Industry 3World Intraocular Lenses Industry 4World Intraocular Lenses Industry 5World Intraocular Lenses Industry 6World Intraocular Lenses Industry 7World Intraocular Lenses Industry 8World Intraocular Lenses Industry 9World Intraocular Lenses Industry 10World Intraocular Lenses Industry 11World Intraocular Lenses Industry 12World Intraocular Lenses Industry 13World Intraocular Lenses Industry 14World Intraocular Lenses Industry 15World Intraocular Lenses Industry 16World Intraocular Lenses Industry 17World Intraocular Lenses Industry 18World Intraocular Lenses Industry 19World Intraocular Lenses Industry 20World Intraocular Lenses Industry 21World Intraocular Lenses Industry 22World Intraocular Lenses Industry 23World Intraocular Lenses Industry 24World Intraocular Lenses Industry 25World Intraocular Lenses Industry 26North America Ultrasound Devices Market Report 2014-2019 - Technology and Applications 2KaloBios Appoints Ronald A. Martell Executive Chairman 2KaloBios Appoints Ronald A. Martell Executive Chairman 3KaloBios Appoints Ronald A. Martell Executive Chairman 4KaloBios Appoints Ronald A. Martell Executive Chairman 5
... Inc. (Nasdaq: VRUS ) announced today the ... of Pharmasset,s PSI-7977, a nucleotide polymerase inhibitor, and BMS-790052, ... replication complex inhibitor, for the treatment of chronic hepatitis ... clinical collaboration agreement between Pharmasset and Bristol-Myers Squibb announced ...
... 26, 2011 Reportlinker.com announces that ... available in its catalogue: ... Steady Uptake of Oxycontin and High ... And Arthritis to Drive the Market ...
Cached Medicine Technology:All-Oral Combination Study with PSI-7977 for HCV Genotypes 1, 2 and 3 Initiated 2All-Oral Combination Study with PSI-7977 for HCV Genotypes 1, 2 and 3 Initiated 3Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 2Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 3Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 4Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 5Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 6Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 7Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 8Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 9Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 10Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 11Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 12Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 13Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 14Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 15Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 16Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 17Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market 18
(Date:5/29/2015)... The annual aesthetic meeting, put on by the American ... from May 14-19th. This global event sets a gold ... world; dedicating itself exclusively to cosmetic medicine. Dr. Paul ... to attend this year’s meeting. , Among the classes ... given the honor of sitting at the presenter’s table during ...
(Date:5/29/2015)... 29, 2015 Vulvodynia is defined as ... significant physical, sexual, and psychological distress. Women’s ... Vulvodynia. The actual diagnosis is often made on the ... realize that this problem can be very troublesome to ... these symptoms, they need to schedule and appointment with ...
(Date:5/29/2015)... Health DataPalooza is a national conference that brings ... the most effective and innovative ways to use open ... by the Health Data Consortium, which is a collaboration ... develop the use of open healthcare data. Within ... in on how to actually put the ideas into ...
(Date:5/29/2015)... News: 2015-2016 Oil Market Forecast, Company: Carson ... , In July, 2014, the price of ... in US shale production and increased production from Saudi ... share from US shale producers, started producing close to ... out into the marketplace, they could push oil prices ...
(Date:5/29/2015)... Texas (PRWEB) May 29, 2015 Testosterone Centers ... the DFW area, is opening a new center in the ... the rest of the Mid Cities. Located on the south ... Road in Hurst, the new testosterone center will open in ... women who suffer from low testosterone. , Like TCT’s other ...
Breaking Medicine News(10 mins):Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 2Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 3Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 3Health News:Breaking News: Carson Energy Releases 2015-2016 Oil Forecast 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 3
... , , , ... TUSTIN, Calif. , July 14 Peregrine Pharmaceuticals, Inc. (Nasdaq: ... (FY) 2009 ended April 30, 2009. Total revenues for the fourth quarter ... in FY 2008. Total revenues for the 2009 fiscal year increased approximately ...
... , NEW YORK, July 14 Delcath Systems, Inc. (Nasdaq: ... for the second quarter ended June 30, 2009 on Monday, July 27, ... Eamonn Hobbs, the Company,s new President & CEO ... 2009 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss ...
... , DEERFIELD BEACH, Fla., July 14 A ... suggests drinking fat-free milk in the morning may be better than drinking ... However, the study only looks at feeling full, not weight loss ... are intolerant to proteins in milk, or lactose intolerant, which can cause ...
... ... under the knife? Advances in fractional laser technology have resulted in the Fractional Eyelift, a ... Bruce Katz of the Juva Skin & Laser Center pioneered the procedure. , ... (PRWEB) July 14, 2009 -- For many, ...
... , ... Institute and EmpowHer Publish a Series of Women,s Cardiovascular Health Content , ... Scottsdale, Arizona (PRWEB) July 14, ... and EmpowHer, ( www.empowher.com ), the home for women,s health online, today announced a ...
... , ... prescription discount card, Niche Prescriptions announces the grand opening of a new program. The ... one of the largest pharmacy networks in the United States and offers thousands of ... ...
Cached Medicine News:Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 2Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 3Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 4Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 5Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 6Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 7Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 8Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 9Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 10Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 11Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 12Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 13Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 14Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 15Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 16Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 17Health News:Delcath Systems to Host July 27th Conference Call to Update Investors on Recent Progress 2Health News:Milk: Does It Do A Body Good? 2Health News:Milk: Does It Do A Body Good? 3Health News:Fractional Eyelift Procedure Reduces Eyelid Drooping and Wrinkles with Minimal Recovery Time 2Health News:Fractional Eyelift Procedure Reduces Eyelid Drooping and Wrinkles with Minimal Recovery Time 3Health News:Free Women's Heart Health Information Now Available 2Health News:Niche Prescriptions Announces Grand Opening of New Program Offering Prescription Drug Discount Card 2Health News:Niche Prescriptions Announces Grand Opening of New Program Offering Prescription Drug Discount Card 3
... will be the world wide sole distributor ... different from conventional drug eluting stents, the ... drug eluting stent designed to provide advanced ... allow release profiles to be tailored to ...
... Terason's background in high performance portable ... the field of echocardiography. Echocardiography ... high frame rates, and sensitive Doppler ... System, based upon Terason's proprietary Teratech ...
... myocardial infarction is suspected, every ... rapid assay allows rapid determination ... T from a single whole ... is available within minutes - ...
For the quantitative determination of human MMP-9/NGAL Complex concentrations in cell culture supernates, serum,plasma, urine and saliva....
Medicine Products: